Philips, a global leader in health technology, has announced a plan for new investments of more than $150 million in US manufacturing and research and development (R&D). As part of this announcement, Philips unveiled the expansion of its Reedsville, PA, manufacturing facility, which produces AI-enabled ultrasound systems for hospitals across the US.
These investments come on top of Philips’ annual $900 million R&D investment in the US as well as investments in nearly 17,000 colleagues across 40 facilities in the United States. Philips has employees in every US state supporting innovations used by clinicians and patients in 90% of hospitals across the country.
The investment announced by Philips includes the expansion of its Reedsville, site and the recently announced expansion of Philips’ Image Guided Therapy facility in Plymouth. It also includes additional manufacturing and R&D projects which will come over the next several years to support the company’s growth in the US.
The Reedsville site, which currently manufactures transducers, will also customize the software and configurations of ultrasound systems for specific clinical procedures in cardiovascular, general and maternal care following the expansion.
The expansion of the Reedsville site is expected to add 24,000 square feet of manufacturing space in addition to 40,000 square feet of warehouse space and is expected to create 120 skilled manufacturing jobs. The recently announced expansion of Philips’ image-guided therapy facility in Plymouth, which includes the construction of a new medtech training center, is expected to create over 150 new jobs.
